Kazia Therapeutics Income Statement

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	2016 - 2020
Operating Revenue	0.04	2.31	-	-	15.18	Upgrade
Other Revenue	1.79	0.17	0	0.01	-	Upgrade
Revenue	1.83	2.48	0	0.01	15.18	Upgrade
Revenue Growth (YoY)	-26.28%	248000.00%	-90.00%	-99.93%	1436.54%	Upgrade
Gross Profit	1.83	2.48	0	0.01	15.18	Upgrade
Selling, General & Admin	8.72	13.56	8.58	5.24	7.02	Upgrade
Research & Development	7.33	17.38	15.56	20.17	14.54	Upgrade
Other Operating Expenses	-	-	-	-0.02	-0	Upgrade
Operating Expenses	16.05	30.94	24.15	25.39	21.56	Upgrade
Operating Income	-14.22	-28.46	-24.15	-25.38	-6.38	Upgrade
Interest & Investment Income	0.07	0.01	0.02	0	0.04	Upgrade
Other Non Operating Income (Expenses)	-2.48	1.28	-	-	-	Upgrade
EBT Excluding Unusual Items	-16.62	-27.17	-24.12	-25.38	-6.34	Upgrade
Asset Writedown	-13.38	-	-	-	-	Upgrade
Other Unusual Items	7.55	0.12	3.39	-	-2.57	Upgrade
Pretax Income	-22.45	-27.05	-20.74	-25.38	-8.91	Upgrade
Income Tax Expense	-1.75	-0.27	-0.27	-0.37	-0.48	Upgrade
Earnings From Continuing Operations	-20.7	-26.78	-20.47	-25.01	-8.42	Upgrade
Net Income	-20.7	-26.78	-20.47	-25.01	-8.42	Upgrade
Net Income to Common	-20.7	-26.78	-20.47	-25.01	-8.42	Upgrade
Shares Outstanding (Basic)	1	1	0	0	0	Upgrade
Shares Outstanding (Diluted)	1	1	0	0	0	Upgrade
Shares Change (YoY)	107.81%	43.08%	39.12%	12.57%	61.08%	Upgrade
EPS (Basic)	-18.89	-50.78	-55.53	-94.42	-35.78	Upgrade
EPS (Diluted)	-18.89	-50.78	-55.53	-94.42	-35.80	Upgrade
Free Cash Flow	-13.28	-9.58	-15.16	-22.76	-9.11	Upgrade
Free Cash Flow Per Share	-12.12	-18.17	-41.12	-85.92	-38.71	Upgrade
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	Upgrade
Operating Margin	-777.31%	-1147.20%	-2414600.00%	-253840.00%	-42.01%	Upgrade
Profit Margin	-1131.88%	-1079.32%	-2046500.00%	-250140.00%	-55.47%	Upgrade
Free Cash Flow Margin	-725.97%	-386.17%	-1515600.00%	-227620.00%	-60.01%	Upgrade
EBITDA	-13.28	-26.59	-22.28	-23.52	-5.11	Upgrade
EBITDA Margin	-	-	-	-	-33.68%	Upgrade
D&A For EBITDA	0.93	1.87	1.87	1.87	1.27	Upgrade
EBIT	-14.22	-28.46	-24.15	-25.38	-6.38	Upgrade
EBIT Margin	-	-	-	-	-42.01%	Upgrade

Updated Nov 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q